Parvolex (acetylcysteine) Disease Interactions
There are 2 disease interactions with Parvolex (acetylcysteine):
Acetylcysteine (Includes Parvolex) ↔ Hepatic Encephalopathy
Severe Potential Hazard, High plausibility
Applies to: Hepatic Coma
The use of acetylcysteine should be discontinued in patients with encephalopathy due to hepatic failure to avoid further administration of nitrogenous substances.
- "Product Information. Mucomyst (acetylcysteine)." Apothecon Inc, Princeton, NJ.
Acetylcysteine (Includes Parvolex) ↔ Gastric Hemorrhage
Moderate Potential Hazard, Moderate plausibility
Applies to: Gastrointestinal Hemorrhage, Peptic Ulcer
The use of acetylcysteine may worsen vomiting. Patients with peptic ulcer disease should be evaluated for the risk of gastrointestinal hemorrhage. In the presence of gastric hemorrhage, the decision to administer this agent should take into consideration the benefits versus the risks to an individual patient.
Parvolex (acetylcysteine) drug Interactions
There are 6 drug interactions with Parvolex (acetylcysteine)
More about Parvolex (acetylcysteine)
Related treatment guides
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.